EHRs from Epic Systems and Cerner please the widest range of specialists, says research firm KLAS, which also reports that oncologists and ophthalmologists are the least happy with their systems.
Medscape Medical News
Daily Archives: 2012/03/22
Medicare Turns Gimlet Eye on DME Drugs
(MedPage Today) -- VEGF inhibitors, such as ranibizumab (Lucentis) or bevacizumab (Avastin), may improve vision in patients with diabetic macular edema, but more research is needed, according to a Medicare advisory panel.
Eye Examination for ARMD: Macular Degeneration
Macular degeneration can only be diagnosed when there are symptoms and findings of the disease. Routine examination in normal situations may not be necessary.
Exonhit 2011 consolidated revenues decrease to € 5.0 million
The Management Board of Exonhit SA met on March 21 to close the consolidated financial accounts for the year ending on December 31, 2011. These accounts were audited by the auditors and verified by the Supervisory Board.
Subscribe
